More specifically, ad libitum total daily energy intake was reduced by 5096 kJ (a relative difference of 38.9%) in patients receiving oral semaglutide versus placebo in the lunch meal, evening meal, and evening snack boxes, resulting in dietary control and pronounced weight loss [48]
It kickstarted something, he told TODAY in September
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
For patients seeking weight loss who request B12 injections, GPs should: Assess for genuine deficiency through appropriate blood tests rather than empirical treatment Provide education about the lack of evidence supporting B12 for weight loss in non-deficient individuals Explore underlying concerns about weight and energy levels, addressing these through appropriate channels Signpost to evidence-based resources such as NHS weight management services according to local pathways Patients should contact their GP if they experience unexplained fatigue, neurological symptoms (numbness, tingling, balance problems), or signs of anaemia (pallor, breathlessness, palpitations), as these may indicate B12 deficiency requiring investigation
While the clinical significance remains uncertain, this raises the theoretical possibility of direct anti-inflammatory or chondroprotective effects
These include: Opiates/narcotics Antispasmodics Tricyclic antidepressants Anti-diarrheal medications like Alosetron, Lomotil and Imodium Proton pump inhibitors Cholestyramine Preventing methane SIBO relapse As discussed above, methane SIBO is generally less susceptible to relapse than hydrogen-dominant SIBO in our experience
